Xia, Chi, H., Wu, Y., Hansen, B. E., Li, Z., Liu, S., Liao, G., Zhang, X., Zhou, B., Hou, J., Sun, J., Janssen, H. L. A., & Peng, J. (2021). Serum hepatitis B virus RNA level is associated with biochemical relapse in patients with chronic hepatitis B infection who discontinue nucleos(t)ide analogue treatment. Alimentary Pharmacology & Therapeutics, 54(5), 709–714. //doi.org/10.1111/apt.16538
Seto, Liu, K. S., Mak, L.-Y., Cloherty, G., Wong, D. K.-H., Gersch, J., Lam, Y.-F., Cheung, K.-S., Chow, N., Ko, K.-L., To, W.-P., Fung, J., & Yuen, M.-F. (2021). Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation. Gut, 70(4), 775–783. //doi.org/10.1136/gutjnl-2020-321116
Xie, Li, M., Ou, X., Zheng, S., Gao, Y., Xu, X., Yang, Y., Ma, A., Li, J., Huang, Y., Nan, Y., Zheng, H., & Feng, B. (2021). HBeAg-positive patients with HBsAg < 100 IU/mL and negative HBV RNA have lower risk of virological relapse after nucleos(t)ide analogues cessation. Journal of Gastroenterology, 56(9), 856–867. //doi.org/10.1007/s00535-021-01812-0
Fan, Peng, J., Xie, Q., Tan, D., Xu, M., Niu, J., Wang, H., Ren, H., Chen, X., Wang, M., Sheng, J., Tang, H., Bai, X., Wu, Y., Zhou, B., Sun, J., & Hou, J. (2020). Combining Hepatitis B Virus RNA and Hepatitis B Core–Related Antigen: Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen–Positive Patients With Chronic Hepatitis B. The Journal of Infectious Diseases, 222(4), 611–618. //doi.org/10.1093/infdis/jiaa136